Archive year 2005

• Aug 10, 2010:
  Archive on www.medicult.com
• Oct 27, 2006:
  MediCult investor presentation 3rd Quarter Results
• Dec 15, 2005:
  MediCult’s Warrant Programmes
• Nov 09, 2005:
  Appointment of a new CEO
• Oct 26, 2005:
  MediCult to conduct proof of concept study on the FF MAS compound from Novo Nordisk
• Oct 18, 2005:
  Extraordinary general meeting on 8 Nov in Oslo, Norway
• Oct 11, 2005:
  MediCult presentation at the DnB NOR Health Care Summit
• Oct 03, 2005:
  MediCult acquires 51% in Italian distributor
• Sep 21, 2005:
  MediCult in-licenses IGF-II
• Sep 19, 2005:
  CEO Lars Rønn leaves MediCult
• Sep 16, 2005:
  MediCult aquires 30% in German Distributor
• Aug 30, 2005:
  MediCult majority shareholder in Italy
• Aug 26, 2005:
  Shares sold by primary insider
• Aug 08, 2005:
  Issue of MediCult a/s warrants
• Jul 28, 2005:
  Financial Statement 1H 2005
• Jul 04, 2005:
  MediCult acquires shareholder position in its German distributor
• Jun 20, 2005:
  MediCult launches two new products for IVF clinics
• Jun 20, 2005:
  MediCult receives 2005 Technology Innovation Award
• Jun 14, 2005:
  MediCult in-licenses invention from the McGill University
• Jun 05, 2005:
  Invitation to a MediCult Meeting in Copenhagen
• May 21, 2005:
  MediCult Annual General Meeting
• Apr 21, 2005:
  Q1 presentation & financial statement
• Apr 21, 2005:
  Shares sold by primary insider
• Apr 04, 2005:
  MediCult a/s (MEC) has obtained market approval of its products in Canada, including its IVM® System
• Apr 01, 2005:
  MediCult a/s (MEC) has signed a Letter of Intent to become shareholder in its German distributor
• Feb 24, 2005:
  Financial Statement for 2004
• Feb 16, 2005:
  Overtrædelse af informationspligten
• Jan 17, 2005:
  MediCult has licensed three inventions from high-profile research institutions